This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Aureo Co., Ltd.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Innovations by Hidekazu Tamegai
Introduction
Hidekazu Tamegai is a notable inventor based in Hatoyama-machi, Japan. He has made significant contributions to the field of macrophage research, particularly in developing compositions that enhance macrophage functions. His work is crucial in advancing therapeutic strategies for cancer treatment.
Latest Patents
Tamegai holds 1 patent for a composition that activates macrophage phagocytosis and promotes cytokine production in macrophages. This innovative composition utilizes an active component derived from natural products, specifically a culture of microorganisms belonging to the genus (sp.). The patent details how this composition can effectively activate macrophage phagocytosis, particularly targeting cancer cells or cells that have been damaged by anticancer drugs.
Career Highlights
Tamegai is associated with Aureo Co., Ltd., where he continues to explore and develop his innovative ideas. His research focuses on enhancing the immune response through macrophage activation, which has the potential to improve cancer therapies significantly.
Collaborations
Tamegai collaborates with Yukiko Moriya, contributing to the advancement of their shared research goals. Their partnership exemplifies the importance of teamwork in scientific innovation.
Conclusion
Hidekazu Tamegai's work in macrophage phagocytosis and cytokine production represents a significant advancement in cancer treatment strategies. His innovative compositions hold promise for enhancing therapeutic outcomes in patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile